Thus, our data clearly illustrated that the FATP5-meidated EMT process is AMPK pathway dependent, and intervention in AMPK signaling may play an essential role in preventing tumor metastasis in low-FATP5-expressing patients. Here, SLC27A5 is linked to neoplasm.